Preclinical Imaging Market

Preclinical Imaging Market by Modality (Micro-MRI, Micro-CT, Micro-ultrasound, Nuclear Imaging Systems, Optical Imaging Systems, Photoacoustic Imaging Systems, and Others) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1234
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 187
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global preclinical imaging market size is projected to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the technological advancement in molecular imaging, rising number of pharmaceuticals companies and clinical research organizations and growing number of pre-clinical imaging systems in vivo research.
 

Preclinical Imaging Market Key Takeaways


Preclinical imaging is the visualization of animals for research purpose. Imaging modalities are used to observe changes of cell, organ, molecular level, and tissue in animals responding to environmental and psychological changes. Small animal models are used in basic and preclinical sciences are main keystone for the research and development strategies. Preclinical imaging techniques help in decreasing of biological variability and the opportunity to acquire large amount of information.

Preclinical imaging helps to understand the underlying mechanism of diseases, provide unique and efficient tools for evaluation of new chemicals entities and candidate drugs. Multimodal molecular imaging plays important role for clinical care of different diseases by improving clinician’s ability to perform staging, screening, planning and therapy guidance, surveillance, prognosis, assessing reassurance, and monitoring therapy efficacy. Rising adoption of computerized research models, lesser research developments, strict rules and regulations imposed by government, which protect animal rights are the key factors restricting the growth of the market.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising funding for supporting preclinical researches is anticipated to push the market growth during the forecast period.
  • Growing demand for non-invasive animal imaging techniques is expected to propel the market expansion in the coming years.
  • Rapid growth of research and development sector is major factor spurring the market growth.
  • High implementation cost in preclinical imaging is expected to restrict the market expansion.
  • Lack of skilled research personnel act as major factor that can impede the market growth.
  • R&D investment and technological advancement in preclinical imaging market is projected to offer immense opportunities for the market players.

Scope of the Report

The report on the global preclinical imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Preclinical Imaging Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Modality (Micro-MRI, Micro-CT, Micro-ultrasound, Nuclear Imaging Systems, Optical Imaging Systems, Photoacoustic Imaging Systems, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Agilent Technologies; Bruker Corporation; MILabs B.V.; Siemens A.G.; Medico Ltd.; General Electric; VisualSonics, Inc.; PerkinElmer, Inc.; and TriFoil Imaging

 

Market Segment Insights:

Micro-ultrasound segment is projected to constitute a major market share
In terms of modality, the global preclinical imaging market is segregated into micro-MRI, micro-CT, micro-ultrasound, nuclear imaging systems, optical imaging systems, photoacoustic imaging systems, and others. The micro-ultrasound segment is expected to account for a key share of the market during the forecast period owing to high usage of micro-ultrasound imaging system in preclinical research studies around the world. Micro-ultrasound is important for imaging modality for research and studies in developmental biology, cardiovascular diseases, and cancer.

It is highly used for assessing placental, maternal, morphology, and haemodynamics, as well as for image guided in teratology and utero interventions. Micro-ultrasound helps to study the normal development and models of human diseases in small animals. It helps the researcher to know the physiological, cellular, and molecular changes in animals and to anticipate the outcome of different new treatments in patients.
 

Preclinical Imaging Market by Modality


North America is anticipated to dominate the market
On the basis of regions, the global preclinical imaging market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to wide usage of technically advanced devices, highly skilled professionals, developed research infrastructure, and large number of preclinical projects. On the other hand, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to rising government funding for development of research and development sector. The growth of clinical research outsourcing industry in various countries such as India and China is expected to drive the market during the forecast period.
 

Preclinical Imaging Market by Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Preclinical Imaging Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Preclinical Imaging Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Preclinical Imaging Market - Supply Chain
  4.5. Global Preclinical Imaging Market Forecast
     4.5.1. Preclinical Imaging Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Preclinical Imaging Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Preclinical Imaging Market Absolute $ Opportunity
5. Global Preclinical Imaging Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Preclinical Imaging Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Preclinical Imaging Demand Share Forecast, 2019-2026
6. North America Preclinical Imaging Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Preclinical Imaging Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Preclinical Imaging Demand Share Forecast, 2019-2026
7. Latin America Preclinical Imaging Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Preclinical Imaging Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Preclinical Imaging Demand Share Forecast, 2019-2026
8. Europe Preclinical Imaging Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Preclinical Imaging Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Preclinical Imaging Demand Share Forecast, 2019-2026
9. Asia Pacific Preclinical Imaging Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Preclinical Imaging Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Preclinical Imaging Demand Share Forecast, 2019-2026
10. Middle East & Africa Preclinical Imaging Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Preclinical Imaging Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Preclinical Imaging Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Preclinical Imaging Market: Market Share Analysis
  11.2. Preclinical Imaging Distributors and Customers
  11.3. Preclinical Imaging Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Segments Covered in the Report
The global preclinical imaging market has been segmented on the basis of

Modality

  • Micro-MRI
  • Micro-CT
  • Micro-ultrasound
  • Nuclear Imaging Systems
  • Optical Imaging Systems
  • Photoacoustic Imaging Systems
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Agilent Technologies
  • Bruker Corporation
  • MILabs B.V.
  • Siemens A.G.
  • Medico Ltd.
  • General Electric
  • VisualSonics, Inc.
  • PerkinElmer, Inc.
  • TriFoil Imaging

Key players competing in the global preclinical imaging market include Agilent Technologies; Bruker Corporation; MILabs B.V.; Siemens A.G.; Medico Ltd.; General Electric; VisualSonics, Inc.; PerkinElmer, Inc.; and TriFoil Imaging. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
 

Preclinical Imaging Market by Key Players

Buy Report